Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Oro-esophageal Tube Feeding in Severe TBI
NCT06199778Terminated
- Start
- Jun 2022
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms). Primary endpoints: Concentration of hemoglobin at Day 28, Concentration of albumin at Day 28 and 2 more. Started Jun 2022; status: terminated.
Beyond the preview
Go deeper on NCT06199778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06199778.